Antibe Therapeutics (ATBPF)
OTHER OTC:ATBPF
US Market
Holding ATBPF?
Track your performance easily

Antibe Therapeutics (ATBPF) Financial Statements

107 Followers

Antibe Therapeutics Financial Overview

Antibe Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.257; its P/E ratio is -0.83; Antibe Therapeutics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -4.21MC$ -5.00MC$ -2.85MC$ -3.11MC$ -4.21M
EBITDAC$ -4.21MC$ -5.00MC$ -2.85MC$ -3.11MC$ -4.21M
Net Income Common StockholdersC$ -4.21MC$ -5.01MC$ -2.85MC$ -3.42MC$ -4.32M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 24.91MC$ 4.14MC$ 8.79MC$ 6.75MC$ 10.53M
Total AssetsC$ 56.36MC$ 60.20MC$ 66.84MC$ 70.56MC$ 73.73M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -24.91MC$ -4.14MC$ -8.79MC$ -6.75MC$ -10.53M
Total LiabilitiesC$ 30.43MC$ 30.50MC$ 32.04MC$ 30.39MC$ 30.47M
Stockholders EquityC$ 25.94MC$ 29.71MC$ 34.80MC$ 40.17MC$ 43.26M
Cash Flow-
Free Cash FlowC$ -3.85MC$ -6.43MC$ -4.58MC$ -3.38MC$ -3.74M
Operating Cash FlowC$ -3.85MC$ -6.43MC$ -4.58MC$ -3.38MC$ -3.73M
Investing Cash FlowC$ 11.04MC$ 1.78MC$ 6.62MC$ -549.00KC$ 532.00K
Financing Cash Flow---C$ 159.00KC$ -1.00K
Currency in CAD

Antibe Therapeutics Earnings and Revenue History

Antibe Therapeutics Debt to Assets

Antibe Therapeutics Cash Flow

Antibe Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis